Pharma / Biotech

Survival Doubled In MBC, but Pts Still Need Support

Although breast cancer remains the second most common cause of death in women, mortality rates are falling, and new targeted drug therapies helped to double progression-free survival in patients with metastatic disease.

Source link

Related posts

Simultaneous quantification of four first line antitubercular drugs and metabolites in human plasma by hydrophilic interaction chromatography and tandem mass spectrometry.


Safety, Tolerability and Pharmacokinetics of Yimitasvir Phosphate Capsule, a Novel Oral Hepatitis C Virus NS5A Inhibitor, in Healthy Chinese Volunteers.


TYLENOL REGULAR STRENGTH (acetaminophen) tablet [Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division]


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy